Education, Science, Technology, Innovation and Life
Open Access
Sign In

The Function of IL-33 in Patients with Guillain-Barré Syndrome

Download as PDF

DOI: 10.23977/medsc.2022.030513 | Downloads: 9 | Views: 451

Author(s)

Jianhui Wang 1, Fanhua Meng 2

Affiliation(s)

1 Neuromedical Center, South China Hospital Affiliated to Shenzhen University, Shenzhen, Guangdong, 518111, China
2 Stroke Ward, Beihua University Affiliated Hospital, Jilin, 132011, Jilin, China

Corresponding Author

Fanhua Meng

ABSTRACT

In recent years, although the development of imaging has greatly facilitated the diagnosis of neurological diseases, it has been less helpful in the diagnosis of peripheral nervous system diseases. The gold standard for diagnosis is difficult to develop due to patient acceptance and ethical constraints. Therefore, the use of immunological methods to detect markers in human body fluids and disease-related markers has become the most important method to study diseases, diagnose and evaluate prognosis. This paper mainly focuses on the analysis and research on the role of IL-33 in patients with Guillain-Barré syndrome. This paper mainly compared the levels of IL-33 and ST2 in different parts of GBS patients with ODINs group, VE/VM group and healthy control group. In the research results, it was found that the incidence of GBS was mostly concentrated in winter and spring, accounting for 30.43% and 33.69%, respectively, followed by summer, accounting for 19.56%, and finally summer, accounting for 16.3%.

KEYWORDS

Interleukin-33, Guillain-Barré Syndrome, Reagent Configuration, ELISA Test

CITE THIS PAPER

Jianhui Wang, Fanhua Meng, The Function of IL-33 in Patients with Guillain-Barré Syndrome. MEDS Clinical Medicine (2022) Vol. 3: 74-83. DOI: http://dx.doi.org/10.23977/medsc.2022.030513.

REFERENCES

[1] Gusniev S A, Polner S A, Mikhaleva L M, et al. Influence of interleukin-33 gene expression on clinical and morphological characteristics of the nasal mucosa in allergic rhinitis[J]. Immunologiya, 2021, 42(1):68-79.
[2] MM Borovcanin, Vesic K. Breast cancer in schizophrenia could be interleukin-33-mediated[J]. World Journal of Psychiatry, 2021, 11(11):1065-1074.
[3] Alkan, Alkan O, Yildirim T, et al. neuroradiology: spinal mri findings of guillain-barré syndrome spinal mri findings of guillain-barré syndrome[J]. Journal of Radiology Case Reports, 2017, 3(3):25-8.
[4] Pietka W, Sundnes O, Zucknick M, et al. Lack of interleukin-33 and its receptor does not prevent calcipotriol-induced atopic dermatitis-like inflammation in mice[J]. Scientific Reports, 2020, 10(1):1-8.
[5] Ramu S, J Calvén, Michaeloudes C, et al. TLR3/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells[J]. ERJ Open Research, 2020, 6(4):00147-2020.
[6] Begum S, Perlman B E, Valero-Pacheco N, et al. Dynamic Expression of Interleukin-33 and ST2 in the Mouse Reproductive Tract Is Influenced by Superovulation [J]. Journal of Histochemistry & Cytochemistry, 2020, 68(4):253-267.
[7] Canolu K, Okutan O, Ta D, et al. Evaluation of serum interleukin-33 and gene polymorphisms in patients with bronchial asthma[J]. Gulhane Medical Journal, 2021, 63(2):104-109.
[8] Milanovic B, Vijatov-Djuric G, Stojsic M, et al. Comparison of serum interleukin-33 levels in children with allergic respiratory diseases[J]. Medicinski Pregled, 2020, 73(3-4):88-93.
[9] Yangngam S, Thongchot S, Pongpaibul A, et al. High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma[J]. Journal of Cancer, 2020, 11(22):6571-6581.
[10] Alvarez P, Bogen O, Levine J D. Nociceptor Interleukin 33 Receptor/ST2 Signaling in Vibration-Induced Muscle Pain in the Rat[J]. The Journal of Pain, 2020, 21( 3–4):506-512.
[11] Al-Hasnawi A, Al-Hasnawi S. Role of interleukin 25 and interleukin 33 as immunological markers in pediatric asthma[J]. Systematic Reviews in Pharmacy, 2020, 14(2):4625-4630.
[12] Indralingam C, Johns S C, Fuster M M, et al. Interleukin-33 Dependent Endothelial Cell Hyperproliferation and Vascular Remodeling in Sugen/Hypoxia Mice[J]. The FASEB Journal, 2020, 34(S1):1-1.

Downloads: 4622
Visits: 200979

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.